Unfortunately, only a few large-scale studies of neurofeedback in addictive disorders have been reported in the literature. Most, if not all of the recommendations previously made regarding further research (Trudeau 2000, 2005b) have yet to be implemented. These recommendations are summarized as follows.Studies require external, systematic replicability of brain wave feedback methods and results in diverse populations that include various control and alternative treatment conditions wherein the groups are matched on key dimensions.Details need to be given regarding the equipment that was used and the associated technical specifications (e.g., details about amplification, filtering, spectral extraction, windowing, and other pertinent information) needed by neurofeedback specialists for replication and comparison.The essential components and durations for brain wave feedback required for therapeutic advantage need to be stated, including double-blinded studies that control for all other possible therapeutic effects.Open clinical trials that investigate efficacy of the types of protocols used for ADHD, PTSD, depression, and TBI remediation with SUD subjects comorbid for those conditions need to be reported.Open clinical trials that assess the efficacy of EEG biofeedback in addressing the specific qEEG changes of
